$AEHR
AEHR TEST SYSTEMS

2023 Q3 Form 10-K Financial Statement

#000165495423011271 Filed on August 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023
Revenue $20.62M $22.27M $64.96M
YoY Change 93.27% 9.76% 27.8%
Cost Of Revenue $10.64M $10.79M $32.22M
YoY Change 71.94% 9.87% 18.59%
Gross Profit $9.981M $11.48M $32.75M
YoY Change 122.74% 9.66% 38.37%
Gross Profit Margin 48.4% 51.55% 50.41%
Selling, General & Admin $3.409M $3.587M $12.24M
YoY Change 35.01% 19.85% 21.8%
% of Gross Profit 34.15% 31.25% 37.37%
Research & Development $2.457M $2.253M $7.134M
YoY Change 64.02% 36.13% 22.62%
% of Gross Profit 24.62% 19.63% 21.79%
Depreciation & Amortization $140.0K $113.0K $450.0K
YoY Change 57.3% 39.51% 46.58%
% of Gross Profit 1.4% 0.98% 1.37%
Operating Expenses $5.866M $5.840M $19.37M
YoY Change 45.81% 25.65% 22.1%
Operating Profit $4.115M $5.639M $13.38M
YoY Change 798.47% -3.11% 71.47%
Interest Expense $580.0K $487.0K $1.245M
YoY Change 379.34% 2113.64% 9476.92%
% of Operating Profit 14.09% 8.64% 9.31%
Other Income/Expense, Net -$6.000K -$4.000K -$3.000K
YoY Change -125.0% -89.47% -110.0%
Pretax Income $4.690M $6.122M $14.62M
YoY Change 677.78% 5.48% 53.2%
Income Tax $16.00K $11.00K $60.00K
% Of Pretax Income 0.34% 0.18% 0.41%
Net Earnings $4.674M $6.111M $14.56M
YoY Change 693.55% 5.47% 54.04%
Net Earnings / Revenue 22.66% 27.44% 22.41%
Basic Earnings Per Share $0.16 $0.52
Diluted Earnings Per Share $0.16 $0.21 $0.50
COMMON SHARES
Basic Shares Outstanding 28.76M shares 27.79M shares
Diluted Shares Outstanding 29.63M shares 29.22M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $51.00M $47.91M $47.91M
YoY Change 41.09% 52.16% 52.16%
Cash & Equivalents $50.96M $30.05M $30.05M
Short-Term Investments $0.00 $17.85M $17.85M
Other Short-Term Assets $500.0K $621.0K $621.0K
YoY Change -39.98% 1.31% 1.31%
Inventory $31.56M $23.91M $23.91M
Prepaid Expenses
Receivables $13.20M $16.59M $16.59M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $96.21M $89.03M $89.03M
YoY Change 62.17% 48.37% 48.37%
LONG-TERM ASSETS
Property, Plant & Equipment $3.083M $8.882M $8.882M
YoY Change 49.52% 638.32% 318.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $222.0K $231.0K $231.0K
YoY Change 18.72% 14.93% 14.93%
Total Long-Term Assets $9.256M $9.113M $9.113M
YoY Change 311.56% 292.63% 292.63%
TOTAL ASSETS
Total Short-Term Assets $96.21M $89.03M $89.03M
Total Long-Term Assets $9.256M $9.113M $9.113M
Total Assets $105.5M $98.14M $98.14M
YoY Change 71.28% 57.46% 57.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.328M $9.206M $9.206M
YoY Change 145.88% 119.45% 119.45%
Accrued Expenses $4.536M $4.280M $4.280M
YoY Change 40.87% 18.56% -2.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.25M $16.31M $16.31M
YoY Change 94.49% 48.07% 48.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $6.100M $6.235M $6.235M
YoY Change 3688.82% 14070.45% 1818.46%
Total Long-Term Liabilities $6.100M $6.235M $6.235M
YoY Change 3688.82% 14070.45% 1818.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.25M $16.31M $16.31M
Total Long-Term Liabilities $6.100M $6.235M $6.235M
Total Liabilities $25.32M $22.54M $22.54M
YoY Change 151.73% 98.81% 98.81%
SHAREHOLDERS EQUITY
Retained Earnings -$47.63M -$52.31M
YoY Change -28.13% -21.77%
Common Stock $288.0K $128.1M
YoY Change -99.76% 47154.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $80.15M $75.60M $75.60M
YoY Change
Total Liabilities & Shareholders Equity $105.5M $98.14M $98.14M
YoY Change 71.28% 57.46% 57.46%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023
OPERATING ACTIVITIES
Net Income $4.674M $6.111M $14.56M
YoY Change 693.55% 5.47% 54.04%
Depreciation, Depletion And Amortization $140.0K $113.0K $450.0K
YoY Change 57.3% 39.51% 46.58%
Cash From Operating Activities $3.901M $5.868M $10.01M
YoY Change -28.57% -865.06% 563.86%
INVESTING ACTIVITIES
Capital Expenditures $284.0K $1.184M $1.362M
YoY Change 238.1% -697.98% 227.4%
Acquisitions $0.00
YoY Change
Other Investing Activities $18.00M $8.000M -$17.29M
YoY Change
Cash From Investing Activities $17.72M $6.816M -$18.66M
YoY Change -21190.48% -3542.42% 4384.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$694.0K 184.0K $7.322M
YoY Change -4.14% -49.03% -71.58%
NET CHANGE
Cash From Operating Activities $3.901M 5.868M $10.01M
Cash From Investing Activities $17.72M 6.816M -$18.66M
Cash From Financing Activities -$694.0K 184.0K $7.322M
Net Change In Cash $20.90M 12.87M -$1.360M
YoY Change 348.23% -2230.46% -105.06%
FREE CASH FLOW
Cash From Operating Activities $3.901M $5.868M $10.01M
Capital Expenditures $284.0K $1.184M $1.362M
Free Cash Flow $3.617M $4.684M $8.649M
YoY Change -32.73% -923.2% 692.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Inventory Net
InventoryNet
15051000 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001040470
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Entity Public Float
EntityPublicFloat
0 usd
CY2022Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.01
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28539000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27120000 shares
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q2 aehr Fair Value Assets Level One To Level Two Transfers Amount
FairValueAssetsLevelOneToLevelTwoTransfersAmount
0 usd
CY2022Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
12859000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
23908000 usd
CY2023Q2 aehr Fair Value Assets Level One To Level Two Transfers Amount
FairValueAssetsLevelOneToLevelTwoTransfersAmount
0 usd
CY2023Q2 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
0 usd
CY2022Q2 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
0 usd
CY2023 us-gaap Employee Stock Ownership Plan Esop Shares Contributed To Esop
EmployeeStockOwnershipPlanESOPSharesContributedToESOP
29832 shares
CY2021 us-gaap Employee Stock Ownership Plan Esop Shares Contributed To Esop
EmployeeStockOwnershipPlanESOPSharesContributedToESOP
36000 shares
CY2022 us-gaap Employee Stock Ownership Plan Esop Shares Contributed To Esop
EmployeeStockOwnershipPlanESOPSharesContributedToESOP
26666 shares
CY2022 aehr Net Gain Loss From Deconsolidation
NetGainLossFromDeconsolidation
0 usd
CY2022 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2023 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2022 aehr Income Tax Benefit Related To Dissolutions Of Subsidiary
IncomeTaxBenefitRelatedToDissolutionsOfSubsidiary
0 usd
CY2023 aehr Income Tax Benefit Related To Dissolutions Of Subsidiary
IncomeTaxBenefitRelatedToDissolutionsOfSubsidiary
0 usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-05-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-22893
CY2023 dei Entity Registrant Name
EntityRegistrantName
AEHR TEST SYSTEMS
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-2424084
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
400 KATO TERRACE
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
FREMONT
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94539
CY2023 dei City Area Code
CityAreaCode
510
CY2023 dei Local Phone Number
LocalPhoneNumber
623-9400
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023 dei Trading Symbol
TradingSymbol
AEHR
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28755426 shares
CY2023 dei Auditor Firm
AuditorFirmId
207
CY2023 dei Auditor Name
AuditorName
BPM LLP
CY2023 dei Auditor Location
AuditorLocation
San Jose, California
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30054000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31484000 usd
CY2023Q2 us-gaap Other Short Term Investments
OtherShortTermInvestments
17853000 usd
CY2022Q2 us-gaap Other Short Term Investments
OtherShortTermInvestments
0 usd
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
16594000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
621000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
613000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
89030000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
60007000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2759000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1203000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6123000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
917000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
231000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
201000 usd
CY2023Q2 us-gaap Assets
Assets
98143000 usd
CY2022Q2 us-gaap Assets
Assets
62328000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
9206000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4195000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4143000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3610000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
137000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
794000 usd
CY2023Q2 aehr Customer Deposits And Deferred Revenue Short Term
CustomerDepositsAndDeferredRevenueShortTerm
2822000 usd
CY2022Q2 aehr Customer Deposits And Deferred Revenue Short Term
CustomerDepositsAndDeferredRevenueShortTerm
2415000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
16308000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11014000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6163000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
212000 usd
CY2023Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
31000 usd
CY2022Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
69000 usd
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
41000 usd
CY2022Q2 us-gaap Other Liabilities
OtherLiabilities
44000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
22543000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
11339000 usd
CY2023Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
285000 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
271000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
127776000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
117686000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-155000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-105000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-52306000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66863000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
75600000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
50989000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
98143000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62328000 usd
CY2023 us-gaap Revenues
Revenues
64961000 usd
CY2022 us-gaap Revenues
Revenues
50829000 usd
CY2021 us-gaap Revenues
Revenues
16600000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
32215000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
27164000 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
10568000 usd
CY2023 us-gaap Gross Profit
GrossProfit
32746000 usd
CY2022 us-gaap Gross Profit
GrossProfit
23665000 usd
CY2021 us-gaap Gross Profit
GrossProfit
6032000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12237000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10047000 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6562000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7134000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5818000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3652000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
19371000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
15865000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
10214000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
13375000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
7800000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-4182000 usd
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1245000 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
13000 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-46000 usd
CY2023 aehr Net Gain From Dissolution Of Aehr Test Systems Japan
NetGainFromDissolutionOfAehrTestSystemsJapan
0 usd
CY2022 aehr Net Gain From Dissolution Of Aehr Test Systems Japan
NetGainFromDissolutionOfAehrTestSystemsJapan
0 usd
CY2021 aehr Net Gain From Dissolution Of Aehr Test Systems Japan
NetGainFromDissolutionOfAehrTestSystemsJapan
2186000 usd
CY2023 aehr Gain From Forgiveness Of Ppp Loan
GainFromForgivenessOfPppLoan
0 usd
CY2022 aehr Gain From Forgiveness Of Ppp Loan
GainFromForgivenessOfPppLoan
1698000 usd
CY2021 aehr Gain From Forgiveness Of Ppp Loan
GainFromForgivenessOfPppLoan
0 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-162000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14617000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9541000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2204000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
60000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
91000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-177000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
14557000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
9450000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-2027000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27785000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26014000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23457000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29215000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27774000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23457000 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
14557000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
9450000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-2027000 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-33000 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-77000 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
160000 usd
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-17000 usd
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2023 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
0 usd
CY2022 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
0 usd
CY2021 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-2401000 usd
CY2023 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
14507000 usd
CY2022 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
9373000 usd
CY2021 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-4268000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
21000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14507000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9373000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4289000 usd
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
14056000 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
580000 usd
CY2021 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-20000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1101000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-2027000 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax
-2401000 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
160000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
11449000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3560000 usd
CY2022 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-429000 usd
CY2022 aehr Proceeds From Public Offerings Net Of Issuance Costs Amount
ProceedsFromPublicOfferingsNetOfIssuanceCostsAmount
24030000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3006000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
9450000 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-77000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
50989000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2562000 usd
CY2023 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-2060000 usd
CY2023 aehr Proceeds From Public Offerings Net Of Issuance Costs Amount
ProceedsFromPublicOfferingsNetOfIssuanceCostsAmount
6820000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2782000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
14557000 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-17000 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-33000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
75600000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
14557000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
9450000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-2027000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
2748000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3006000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1101000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
24000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
450000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
356000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
328000 usd
CY2023 aehr Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
88000 usd
CY2022 aehr Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
-49000 usd
CY2021 aehr Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
-18000 usd
CY2023 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-576000 usd
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 usd
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 usd
CY2023 aehr Net Gain From Dissolution Of Aehr Test Systems
NetGainFromDissolutionOfAehrTestSystems
0 usd
CY2022 aehr Net Gain From Dissolution Of Aehr Test Systems
NetGainFromDissolutionOfAehrTestSystems
0 usd
CY2021 aehr Net Gain From Dissolution Of Aehr Test Systems
NetGainFromDissolutionOfAehrTestSystems
-2186000 usd
CY2023 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0 usd
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0 usd
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
-215000 usd
CY2023 aehr Gain From Forgiveness Of Ppp Loan1
GainFromForgivenessOfPppLoan1
0 usd
CY2022 aehr Gain From Forgiveness Of Ppp Loan1
GainFromForgivenessOfPppLoan1
-1698000 usd
CY2021 aehr Gain From Forgiveness Of Ppp Loan1
GainFromForgivenessOfPppLoan1
0 usd
CY2023 aehr Increase Decrease In Trade And Other Accounts Receivable
IncreaseDecreaseInTradeAndOtherAccountsReceivable
-3788000 usd
CY2022 aehr Increase Decrease In Trade And Other Accounts Receivable
IncreaseDecreaseInTradeAndOtherAccountsReceivable
-7834000 usd
CY2021 aehr Increase Decrease In Trade And Other Accounts Receivable
IncreaseDecreaseInTradeAndOtherAccountsReceivable
-1373000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9469000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6674000 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-972000 usd
CY2023 aehr Increase Decrease In Prepaid Expense And Other Assets
IncreaseDecreaseInPrepaidExpenseAndOtherAssets
28000 usd
CY2022 aehr Increase Decrease In Prepaid Expense And Other Assets
IncreaseDecreaseInPrepaidExpenseAndOtherAssets
-71000 usd
CY2021 aehr Increase Decrease In Prepaid Expense And Other Assets
IncreaseDecreaseInPrepaidExpenseAndOtherAssets
-81000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5044000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1356000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1877000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
528000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1464000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
732000 usd
CY2023 aehr Increase Decrease In Customer Deposits And Deferred Revenue
IncreaseDecreaseInCustomerDepositsAndDeferredRevenue
369000 usd
CY2022 aehr Increase Decrease In Customer Deposits And Deferred Revenue
IncreaseDecreaseInCustomerDepositsAndDeferredRevenue
2196000 usd
CY2021 aehr Increase Decrease In Customer Deposits And Deferred Revenue
IncreaseDecreaseInCustomerDepositsAndDeferredRevenue
96000 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0 usd
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
47000 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
8000 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
6000 usd
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-10000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10011000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1508000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2701000 usd
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
33294000 usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
CY2023 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
16000000 usd
CY2022 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
0 usd
CY2021 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
0 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1362000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
416000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
227000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18656000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-416000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-227000 usd
CY2023 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1400000 usd
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1400000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2562000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3560000 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
580000 usd
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2060000 usd
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
429000 usd
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
20000 usd
CY2023 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
6820000 usd
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
24030000 usd
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7322000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25761000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1960000 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-37000 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49000 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1360000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
26902000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-851000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31564000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4662000 usd
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5513000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30204000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31564000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4662000 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
21000 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
4000 usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
15000 usd
CY2023 us-gaap Interest Paid
InterestPaid
15000 usd
CY2022 us-gaap Interest Paid
InterestPaid
12000 usd
CY2021 us-gaap Interest Paid
InterestPaid
6000 usd
CY2023 aehr Net Transfer Of Equipment Between Inventory And Property And Equipment
NetTransferOfEquipmentBetweenInventoryAndPropertyAndEquipment
646000 usd
CY2022 aehr Net Transfer Of Equipment Between Inventory And Property And Equipment
NetTransferOfEquipmentBetweenInventoryAndPropertyAndEquipment
472000 usd
CY2021 aehr Net Transfer Of Equipment Between Inventory And Property And Equipment
NetTransferOfEquipmentBetweenInventoryAndPropertyAndEquipment
113000 usd
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
16594000 usd
CY2022Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
12859000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
24000 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:45px">The Company sells its products primarily to semiconductor manufacturers in North America, Asia, and Europe. As of May 31, 2023, approximately 17% and 83% of gross accounts receivable were from customers located in North America and Asia, respectively. As of May 31, 2022, approximately 20% and 80% of gross accounts receivable were from customers located in North America and Asia, respectively. Two customers accounted for 82% and 17% of gross accounts receivable as of May 31, 2023. Three customers accounted for 68%, 18% and 11% of gross accounts receivable as of May 31, 2022. Two customers accounted for 79% and 10% of net sales in fiscal 2023, respectively. One customer accounted for 82% of net sales in fiscal 2022. The Company performs ongoing credit evaluations of its customers and generally does not require collateral. The Company uses letter of credit terms for some of its international customers.</p><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:45px"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:45px">The Company’s cash and cash equivalents are generally deposited with major financial institutions in the United States, Philippines, Germany and Taiwan. The Company invests its excess cash in money market funds and U.S. Treasury securities. The money market funds bear the risk associated with each fund. The money market funds have variable interest rates. The Company’s cash and investment balances held at banks and brokerage firms may at time exceed federally insured levels. The Company has not experienced any material losses on its money market funds or short-term cash deposits.</p>
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
569000 usd
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1031000 usd
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
176000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023 aehr Schedule Of Useful Life For Property And Equipment Table Textblock
ScheduleOfUsefulLifeForPropertyAndEquipmentTableTextblock
<table cellpadding="0" style="border-spacing:0;font-size:10pt;text-align:justify;width:50%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Furniture and fixtures   </p></td><td style="width:15%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2 to 6 years</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Machinery and equipment</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3 to 6 years</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Test equipment   </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4 to 6 years</p></td></tr></tbody></table>
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
16594000 usd
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
12859000 usd
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
13000 usd
CY2021 aehr Gain Loss Related To Completed Liquidation
GainLossRelatedToCompletedLiquidation
2401000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16600000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16600000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16600000 usd
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
189000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
163000 usd
CY2023Q2 aehr Investor Relations
InvestorRelations
79000 usd
CY2022Q2 aehr Investor Relations
InvestorRelations
44000 usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
22000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-2027000 usd
CY2023 aehr Shares Used In Basic Net Income Loss Per Share Calculation
SharesUsedInBasicNetIncomeLossPerShareCalculation
27785000 shares
CY2022 aehr Shares Used In Basic Net Income Loss Per Share Calculation
SharesUsedInBasicNetIncomeLossPerShareCalculation
26014000 shares
CY2021 aehr Shares Used In Basic Net Income Loss Per Share Calculation
SharesUsedInBasicNetIncomeLossPerShareCalculation
23457000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23457000 shares
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
150000 usd
CY2023 us-gaap Depreciation
Depreciation
450000 usd
CY2022 us-gaap Depreciation
Depreciation
307000 usd
CY2021 us-gaap Depreciation
Depreciation
310000 usd
CY2023Q2 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
1728000 usd
CY2022Q2 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
1505000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1491000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1401000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
267000 usd
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
410000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
520000 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
204000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
36000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
33000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4143000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3610000 usd
CY2023Q2 aehr Customer Deposits And Deferred Revenue Short Term
CustomerDepositsAndDeferredRevenueShortTerm
2822000 usd
CY2022Q2 aehr Customer Deposits And Deferred Revenue Short Term
CustomerDepositsAndDeferredRevenueShortTerm
2415000 usd
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-28000 usd
CY2022 us-gaap Other Comprehensive Income Loss Before Reclassifications Tax
OtherComprehensiveIncomeLossBeforeReclassificationsTax
-77000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-105000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
14541000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
9416000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-13064000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
76000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
125000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
10860000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14617000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9541000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2204000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-28000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-59000 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
163000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-5000 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
13000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-32000 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-27000 usd
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1000 usd
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
60000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
91000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-177000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.001 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.006 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.007 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.003 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.098 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.091 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.110 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.047 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.023 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.013 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.040 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.093 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.047 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.321 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0.098 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.037 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.006 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.004 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.004 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.004 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.011 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.080 pure
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11964000 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14912000 usd
CY2023Q2 aehr Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
1335000 usd
CY2022Q2 aehr Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
218000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
6235000 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
5535000 usd
CY2023Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
938000 usd
CY2022Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
934000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
1200000 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
1360000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
1187000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
0 usd
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
297000 usd
CY2022Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
220000 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21859000 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22980000 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1297000 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
199000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-1297000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-199000 usd
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1121000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-278000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2438000 usd
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1852000 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
11000 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
65000 usd
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1928000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
12000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
78000 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2018000 usd
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
90000 usd
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
168000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2276000 usd
CY2023 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
5900000 usd
CY2023 aehr Operating Lease Weighted Average Remaining Lease Term During Period
OperatingLeaseWeightedAverageRemainingLeaseTermDuringPeriod
P7Y3M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.075 pure
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
923000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
766000 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
761000 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
835000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
813000 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
779000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
608000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1143000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1174000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1195000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1234000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3075000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8429000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2129000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
6300000 usd
CY2023 aehr Net Stock Based Compensation
NetStockBasedCompensation
2748000 usd
CY2022 aehr Net Stock Based Compensation
NetStockBasedCompensation
2923000 usd
CY2021 aehr Net Stock Based Compensation
NetStockBasedCompensation
1101000 usd
CY2023 aehr Effect On Net Income Loss Per Share Basic
EffectOnNetIncomeLossPerShareBasic
0.10
CY2022 aehr Effect On Net Income Loss Per Share Basic
EffectOnNetIncomeLossPerShareBasic
0.11
CY2021 aehr Effect On Net Income Loss Per Share Basic
EffectOnNetIncomeLossPerShareBasic
0.05
CY2023 aehr Effect On Net Income Loss Per Share Diluted
EffectOnNetIncomeLossPerShareDiluted
0.09
CY2022 aehr Effect On Net Income Loss Per Share Diluted
EffectOnNetIncomeLossPerShareDiluted
0.11
CY2021 aehr Effect On Net Income Loss Per Share Diluted
EffectOnNetIncomeLossPerShareDiluted
0.05
CY2023 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
120000 usd
CY2022 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
83000 usd
CY2021 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
0 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
17088000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
12542000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
152000 usd
CY2023Q2 aehr Share Based Compensation Arrangement By Share Based Payment Award Option Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisableNumber
620000 shares
CY2022Q2 aehr Share Based Compensation Arrangement By Share Based Payment Award Option Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisableNumber
1042000 shares
CY2021Q2 aehr Share Based Compensation Arrangement By Share Based Payment Award Option Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisableNumber
2045000 shares
CY2023Q2 aehr Weighted Average Exercise Price For Options Exercisable
WeightedAverageExercisePriceForOptionsExercisable
2.56
CY2022Q2 aehr Weighted Average Exercise Price For Options Exercisable
WeightedAverageExercisePriceForOptionsExercisable
2.22
CY2021Q2 aehr Weighted Average Exercise Price For Options Exercisable
WeightedAverageExercisePriceForOptionsExercisable
2.26
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
240000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
96000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
207000 shares
CY2023 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
178000 shares
CY2022 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
62000 shares
CY2021 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
9000 shares
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
4.47
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
3.12
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.90
CY2023 aehr Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Perio
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPerio
30000 shares
CY2022 aehr Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Perio
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPerio
10000 shares
CY2021 aehr Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Perio
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPerio
1000 shares
CY2023 aehr Weighted Average Grant Date Fair Value Of Cancelled Rsus
WeightedAverageGrantDateFairValueOfCancelledRsus
8.56
CY2022 aehr Weighted Average Grant Date Fair Value Of Cancelled Rsus
WeightedAverageGrantDateFairValueOfCancelledRsus
2.93
CY2021 aehr Weighted Average Grant Date Fair Value Of Cancelled Rsus
WeightedAverageGrantDateFairValueOfCancelledRsus
3.46
CY2023 aehr Share Based Compensation Arrangement By Share Based Payment Awards Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardsEquityInstrumentsOtherThanOptionsNonvestedNumber
345000 shares
CY2022 aehr Share Based Compensation Arrangement By Share Based Payment Awards Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardsEquityInstrumentsOtherThanOptionsNonvestedNumber
185000 shares
CY2021 aehr Share Based Compensation Arrangement By Share Based Payment Awards Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardsEquityInstrumentsOtherThanOptionsNonvestedNumber
132000 shares
CY2023 aehr Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value Rs Usand Prs Us
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValueRSUsandPRSUs
6.40
CY2022 aehr Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value Rs Usand Prs Us
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValueRSUsandPRSUs
3.00
CY2021 aehr Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value Rs Usand Prs Us
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValueRSUsandPRSUs
1.88
CY2023 aehr Sharebased Compensation Arrangement By Sharebased Payments Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentsAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
11392000 usd
CY2022 aehr Sharebased Compensation Arrangement By Sharebased Payments Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentsAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
1554000 usd
CY2021 aehr Sharebased Compensation Arrangement By Sharebased Payments Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentsAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
297000 usd
CY2023 us-gaap Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
The stock bonus plan was converted to an employee stock ownership plan (“ESOP”) to enable the Plan to better comply with changes in the law regarding Company stock. Individuals’ account balances vest at a rate of 20% per year commencing upon completion of two years of service
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
300000 usd
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
250000 usd
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
60000 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3000 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
32000 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-111000 usd
CY2022 aehr Other Nonoperating Income Expensegross
OtherNonoperatingIncomeExpensegross
-2000 usd
CY2021 aehr Other Nonoperating Income Expensegross
OtherNonoperatingIncomeExpensegross
-51000 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-162000 usd
CY2021 aehr Net Gain Loss From Deconsolidation
NetGainLossFromDeconsolidation
2401000 usd
CY2021 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
2186000 usd
CY2021 aehr Income Tax Benefit Related To Dissolutions Of Subsidiary
IncomeTaxBenefitRelatedToDissolutionsOfSubsidiary
215000 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
150000 usd
CY2023Q2 us-gaap Purchase Obligation
PurchaseObligation
26318000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001654954-23-011271-index-headers.html Edgar Link pending
0001654954-23-011271-index.html Edgar Link pending
0001654954-23-011271.txt Edgar Link pending
0001654954-23-011271-xbrl.zip Edgar Link pending
aehr-20230531.xsd Edgar Link pending
aehr_10k.htm Edgar Link pending
aehr_ex231.htm Edgar Link pending
aehr_ex311.htm Edgar Link pending
aehr_ex312.htm Edgar Link pending
aehr_ex321.htm Edgar Link pending
aehr-20230531_cal.xml Edgar Link unprocessable
aehr-20230531_pre.xml Edgar Link unprocessable
aehr-20230531_def.xml Edgar Link unprocessable
aehr-20230531_lab.xml Edgar Link unprocessable
aehr_10k_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending